C M BIDWELL & ASSOCIATES LTD
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1091860
HONOLULU, HI
Position in AMRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$93,733
+$93,083 QoQ
Shares Held
5,415
+8230.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#221
of 305 holders
Holding Since
Jun 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026C M BIDWELL & ASSOCIATES LTD holds $588,931 across 7 Drug Manufacturers - Specialty & Generic names. AMRX ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
1,369 | $230,731 | |
| 2 | ALKS |
Alkermes plc.
|
1,981 | $103,804 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
5,415 | $93,733 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,895 | $77,751 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
916 | $75,826 | |
| 6 | LQDA |
Liquidia Corp
|
77 | $6,139 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
225 | $947 |
All Filings in AMRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,733 | 5,415 | Shares | Sole | 2026-08-11 | |
| 2025-09-30 | $650 | 65 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $525 | 65 | Shares | Sole | 2025-08-14 | |
| 2020-06-30 | $140,658 | 29,550 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||